ThePeptide

Retatrutide 10mg

$99.00 CAD

Sale Sold out

Size 10mg

This compound requires bacteriostatic water for reconstitution.

⚠️ Under no circumstances should any products be used without the express direction of a licensed physician.

Janoshik Analytical

Lab Result: Retatrutide 10mg PP2604

Avg. purity

99.2%

Avg. mass

10.08 mg

Result date

May 16, 2026

Date added

May 19, 2026

Each vial contains highly pure Retatrutide.

Retatrutide is a novel triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. It represents the next generation of metabolic research compounds beyond semaglutide and tirzepatide. Administered subcutaneously once per week, it activates all three incretin and glucagon pathways — enhancing insulin secretion, suppressing appetite, slowing gastric emptying, and increasing energy expenditure.

Key Research Areas

Triple receptor agonism: GIP, GLP-1, and glucagon
Thermogenesis and energy expenditure studies
Adipose tissue reduction in research models
Insulin sensitivity and glucose metabolism research
Cardiovascular risk factor investigation

Mechanism of Action

In research models, simultaneous activation of three metabolic receptors produces complementary effects on energy intake and expenditure. The glucagon receptor component adds thermogenic activity not observed in dual agonists, as demonstrated in published Phase 2 clinical data.

For use by qualified researchers in controlled laboratory settings only.

Add 2mL of bacteriostatic water to get a solution that is 5mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 0.5mg (500mcg) of Retatrutide.

Lyophilized (unreconstituted): Store at −20°C. Stable for 24+ months when sealed.
After reconstitution: Refrigerate at 2–8°C. Use within 28 days.
Light & heat: Protect from direct light and heat at all times.
Do not freeze reconstituted solution. Freeze-thaw cycles degrade peptide integrity.

CAS Number: 2381089-91-2
Molecular Weight: 4,765.47 g/mol
Form: Lyophilized powder in sterile vial
Purity: ≥99% (HPLC verified)

Test	Method	Result
Identity	LC-MS/MS	Confirmed ✓
Purity (HPLC)	HPLC-UV	≥99% ✓
Appearance	Visual	White lyophilized powder ✓
Endotoxin	LAL method	<1 EU/mg ✓
Heavy metals	ICP-MS	Pass ✓
Sterility	USP <71>	Pass ✓

Independent third-party testing by Janoshik Analytical. Full batch reports available on our lab results page.

Peer-reviewed publications for research reference only.

Jastreboff et al., 2023 · PMID 37366315Coskun et al., 2022 · PMID 35953067

Research use only. This product is sold exclusively for in-vitro laboratory research and scientific study. It is not a drug, supplement, food, or cosmetic. It has not been approved by Health Canada, the FDA, or any regulatory authority for therapeutic, diagnostic, or preventative use in humans or animals.

Not for human or animal use. This product must not be administered to, consumed by, or used on humans or animals under any circumstances.

By purchasing this product, you confirm that you are a qualified researcher, that you will use this product solely for lawful in-vitro research purposes, and that you accept full responsibility for compliance with all applicable regulations.

View full details